Free Trial
NASDAQ:YI

111 Q2 2026 Earnings Results & Report

111 logo
$3.25 +0.11 (+3.44%)
As of 12:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.

111 reported Q2 2026 earnings on September 18, 2026. The company reported EPS of -$0.60, while revenue was $338.55 million.

Earnings Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Conference Call
9:30 AM ET

111 EPS Results

Actual EPS
-$0.60
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

111 Revenue Results

Actual Revenue
$338.55 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

111's Q3 2026 earnings is estimated for Thursday, November 26, 2026, based on past reporting schedules

Earnings Documents

111 Q2 2026 Earnings FAQ

111 (NASDAQ:YI) reported earnings of -$0.60 per share for Q2 2026. The report was announced on Friday, September 18, 2026.

111 reported revenue of $338.55 million for Q2 2026.

111's next earnings date is estimated for Thursday, November 26, 2026. MarketBeat tracks confirmed and estimated earnings dates for 111 on the company's earnings history page.

111 Earnings Headlines

Comparing Option Care Health (NASDAQ:OPCH) & 111 (NASDAQ:YI)
111, Inc. Announces Establishment of Special Committee
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
111, Inc. Announces Establishment of the Special Committee
111, Inc Q2 Loss Widens From Lower Revenue; Shares Up
See More 111 Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 111? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 111 and other key companies, straight to your email.

About 111

111 (NASDAQ:YI), Inc. (NASDAQ: YI) is a China-based technology-enabled healthcare platform that connects consumers, healthcare providers, pharmacies and pharmaceutical companies. The company focuses on improving access to healthcare products and services through digital tools and an integrated online and offline operating model.

Its business activities include online retailing and distribution of prescription and over-the-counter medicines, health products, medical devices and other healthcare-related goods. Through its digital platforms, 111 also provides medication information, health-management resources and other services intended to support consumers and healthcare professionals.

111 serves customers and business partners primarily in China. The company was founded in 2010 and has developed operations spanning consumer healthcare, pharmaceutical distribution and technology services. Its platforms are designed to connect pharmaceutical manufacturers with hospitals, pharmacies, clinics and individual consumers across the Chinese healthcare market.

111, Inc. was co-founded by Junling Liu, who has served as the company’s chief executive officer. The company completed its initial public offering on the Nasdaq Stock Market in 2018.

View 111 Profile